BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1153678)

  • 21. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the effects of several psychotropic drugs by gross behavioral observation on rhesus monkeys].
    Kato S; Yanagita T
    Yakubutsu Seishin Kodo; 1981 Oct; 1(1):29-37. PubMed ID: 7187791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of serotonin (5-hydroxytryptamine) on the formation of adenosine 3',5'-phosphate by tissue particles from the liver fluke, Fasciola hepatica.
    MANSOUR TE; SUTHERLAND EW; RALL TW; BUEDING E
    J Biol Chem; 1960 Feb; 235():466-70. PubMed ID: 14420764
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced cues in studying mechanisms of drug action.
    Rosecrans JA; Glennon RA
    Neuropharmacology; 1979 Dec; 18(12):981-9. PubMed ID: 530379
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of various centrally-acting drugs on hepatic steroid metabolism in male and female rats.
    Skett P; Mode A; Eneroth P; Gustafsson JA
    Biochem Pharmacol; 1979 Mar; 28(6):719-22. PubMed ID: 454470
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of hormones on carbohydrate metabolism of invertebrates.
    Mansour TE
    Fed Proc; 1967; 26(4):1179-85. PubMed ID: 4226286
    [No Abstract]   [Full Text] [Related]  

  • 27. [The modification by their antagonists of the effects of serotonin and noradrenaline on a conditioned escape reaction in the rat].
    Matthies H; Schmidt J; Krüger H; Horenburg R
    Acta Biol Med Ger; 1971; 26(2):347-53. PubMed ID: 4401185
    [No Abstract]   [Full Text] [Related]  

  • 28. Unexplained inhibitory action of D-lysergic acid diethylamide (LSD) on postganglionic motor transmission in the guinea-pig vas deferens.
    Ambache N; Dunk LP; Miall P; Zar MA
    Br J Pharmacol; 1971 Aug; 42(4):659P-660P. PubMed ID: 4329987
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacological characteristics of pulmonary serotonin-reactive structures responsible for respiratory chemoreflexes to serotonin].
    Pidevich IN; Demina LM
    Biull Eksp Biol Med; 1971 Dec; 72(12):45-7. PubMed ID: 5132138
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment.
    Wang RY; Aghajanian GK
    Commun Psychopharmacol; 1980; 4(1):83-90. PubMed ID: 7398246
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of endogenic substances in creating a background of increased radioresistance. 3. The role of endogenic serotonin].
    Sobolev AS; Zhamsaranova SD; Orekhov AN; Goncharenko EN; Kudriashov IuB
    Radiobiologiia; 1974; 14(1):78-82. PubMed ID: 4274499
    [No Abstract]   [Full Text] [Related]  

  • 33. [A pharmacologic analysis of several adrenomimetic effects of serotonin].
    Arefolov VA; Pidevich IN; Panasiuk LV; Firsov VK
    Biull Eksp Biol Med; 1975 Nov; 80(11):45-8. PubMed ID: 1218259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB; West WB; Buggy J
    Neurosci Biobehav Rev; 2004 Jan; 27(8):693-701. PubMed ID: 15019419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of mexamine on central effects of lysergic acid diethylamide].
    Mil'shteĭn GI
    Farmakol Toksikol; 1966; 29(6):662-5. PubMed ID: 6000361
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lysergic acid diethylamide (LSD-25) test and psychotropic therapy: electroencephalographic study].
    Borenstein P; Cujo P; Olivenstein C
    Ann Med Psychol (Paris); 1965 Jul; 123(2):237-46. PubMed ID: 5852791
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the pharmacological characteristics of the serotonin-reactive structures of the heart].
    Kaverina NV; Kareva GF; Pidevich IN
    Farmakol Toksikol; 1965; 28(5):536-9. PubMed ID: 5875812
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopamine and serotonin. Involvement in the central effects of psychotropic agents].
    Hamon M
    Encephale; 1989; 15 Spec No():119-25. PubMed ID: 2663442
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 40. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.